Synovial Sarcoma Treatment Market

List of Tables
Table 1. Synovial Sarcoma Treatment CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Synovial Sarcoma Treatment Market Trends
Table 3. Synovial Sarcoma Treatment Market Drivers
Table 4. Synovial Sarcoma Treatment Market Challenges
Table 5. Synovial Sarcoma Treatment Market Restraints
Table 6. Global Synovial Sarcoma Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Synovial Sarcoma Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Synovial Sarcoma Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Synovial Sarcoma Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Synovial Sarcoma Treatment Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Synovial Sarcoma Treatment Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Synovial Sarcoma Treatment Revenue Share by Manufacturer, 2017-2022
Table 13. Global Synovial Sarcoma Treatment Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Synovial Sarcoma Treatment Sales Share by Manufacturer, 2017-2022
Table 15. Global Synovial Sarcoma Treatment Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Synovial Sarcoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Synovial Sarcoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synovial Sarcoma Treatment as of 2021)
Table 18. Top Players of Synovial Sarcoma Treatment in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Synovial Sarcoma Treatment Product Type
Table 20. Date of International Manufacturers Enter into Synovial Sarcoma Treatment Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Synovial Sarcoma Treatment Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Synovial Sarcoma Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Synovial Sarcoma Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Synovial Sarcoma Treatment Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Synovial Sarcoma Treatment Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Synovial Sarcoma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Synovial Sarcoma Treatment Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Synovial Sarcoma Treatment Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Synovial Sarcoma Treatment Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Synovial Sarcoma Treatment Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Synovial Sarcoma Treatment Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Synovial Sarcoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Synovial Sarcoma Treatment Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Synovial Sarcoma Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Synovial Sarcoma Treatment Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Synovial Sarcoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Synovial Sarcoma Treatment Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Synovial Sarcoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Synovial Sarcoma Treatment Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Synovial Sarcoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Adaptimmune Therapeutics Plc Corporation Information
Table 43. Adaptimmune Therapeutics Plc Description and Business Overview
Table 44. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product
Table 46. Adaptimmune Therapeutics Plc Recent Development
Table 47. Advenchen Laboratories LLC Corporation Information
Table 48. Advenchen Laboratories LLC Description and Business Overview
Table 49. Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Advenchen Laboratories LLC Product
Table 51. Advenchen Laboratories LLC Recent Development
Table 52. EpiZyme Inc Corporation Information
Table 53. EpiZyme Inc Description and Business Overview
Table 54. EpiZyme Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. EpiZyme Inc Product
Table 56. EpiZyme Inc Recent Development
Table 57. Immune Design Corp Corporation Information
Table 58. Immune Design Corp Description and Business Overview
Table 59. Immune Design Corp Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Immune Design Corp Product
Table 61. Immune Design Corp Recent Development
Table 62. Immunocore Ltd Corporation Information
Table 63. Immunocore Ltd Description and Business Overview
Table 64. Immunocore Ltd Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Immunocore Ltd Product
Table 66. Immunocore Ltd Recent Development
Table 67. Johnson & Johnson Corporation Information
Table 68. Johnson & Johnson Description and Business Overview
Table 69. Johnson & Johnson Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Johnson & Johnson Product
Table 71. Johnson & Johnson Recent Development
Table 72. Karyopharm Therapeutics Inc Corporation Information
Table 73. Karyopharm Therapeutics Inc Description and Business Overview
Table 74. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Karyopharm Therapeutics Inc Product
Table 76. Karyopharm Therapeutics Inc Recent Development
Table 77. Merck & Co Inc Corporation Information
Table 78. Merck & Co Inc Description and Business Overview
Table 79. Merck & Co Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Merck & Co Inc Product
Table 81. Merck & Co Inc Recent Development
Table 82. Millennium Pharmaceuticals Inc Corporation Information
Table 83. Millennium Pharmaceuticals Inc Description and Business Overview
Table 84. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Millennium Pharmaceuticals Inc Product
Table 86. Millennium Pharmaceuticals Inc Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. Pfizer Inc Corporation Information
Table 93. Pfizer Inc Description and Business Overview
Table 94. Pfizer Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Pfizer Inc Product
Table 96. Pfizer Inc Recent Development
Table 97. Takara Bio Inc Corporation Information
Table 98. Takara Bio Inc Description and Business Overview
Table 99. Takara Bio Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Takara Bio Inc Product
Table 101. Takara Bio Inc Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Synovial Sarcoma Treatment Customers List
Table 105. Synovial Sarcoma Treatment Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Synovial Sarcoma Treatment Product Picture
Figure 2. Global Synovial Sarcoma Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Synovial Sarcoma Treatment Market Size 2017-2028 (US$ Million)
Figure 4. Global Synovial Sarcoma Treatment Sales 2017-2028 (K Pcs)
Figure 5. United States Synovial Sarcoma Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Synovial Sarcoma Treatment Market Size 2017-2028 (US$ Million)
Figure 7. United States Synovial Sarcoma Treatment Sales 2017-2028 (K Pcs)
Figure 8. United States Synovial Sarcoma Treatment Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Synovial Sarcoma Treatment Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Synovial Sarcoma Treatment Report Years Considered
Figure 11. Product Picture of ACXT-3102
Figure 12. Product Picture of AL-3818
Figure 13. Product Picture of Axitinib
Figure 14. Product Picture of CMB-305
Figure 15. Product Picture of CUE-102
Figure 16. Product Picture of Others
Figure 17. Global Synovial Sarcoma Treatment Market Share by Type in 2022 & 2028
Figure 18. Global Synovial Sarcoma Treatment Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Synovial Sarcoma Treatment Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Synovial Sarcoma Treatment Sales by Type (2017-2028) & (K Pcs)
Figure 21. Global Synovial Sarcoma Treatment Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Synovial Sarcoma Treatment Price by Type (2017-2028) & (USD/Pcs)
Figure 23. United States Synovial Sarcoma Treatment Market Share by Type in 2022 & 2028
Figure 24. United States Synovial Sarcoma Treatment Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Synovial Sarcoma Treatment Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Synovial Sarcoma Treatment Sales by Type (2017-2028) & (K Pcs)
Figure 27. United States Synovial Sarcoma Treatment Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Synovial Sarcoma Treatment Price by Type (2017-2028) & (USD/Pcs)
Figure 29. Product Picture of Hospital
Figure 30. Product Picture of Clinic
Figure 31. Product Picture of Others
Figure 32. Global Synovial Sarcoma Treatment Market Share by Application in 2022 & 2028
Figure 33. Global Synovial Sarcoma Treatment Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Synovial Sarcoma Treatment Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Synovial Sarcoma Treatment Sales by Application (2017-2028) & (K Pcs)
Figure 36. Global Synovial Sarcoma Treatment Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Synovial Sarcoma Treatment Price by Application (2017-2028) & (USD/Pcs)
Figure 38. United States Synovial Sarcoma Treatment Market Share by Application in 2022 & 2028
Figure 39. United States Synovial Sarcoma Treatment Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Synovial Sarcoma Treatment Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Synovial Sarcoma Treatment Sales by Application (2017-2028) & (K Pcs)
Figure 42. United States Synovial Sarcoma Treatment Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Synovial Sarcoma Treatment Price by Application (2017-2028) & (USD/Pcs)
Figure 44. North America Synovial Sarcoma Treatment Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. North America Synovial Sarcoma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Synovial Sarcoma Treatment Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 49. Europe Synovial Sarcoma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Synovial Sarcoma Treatment Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 56. Asia-Pacific Synovial Sarcoma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Synovial Sarcoma Treatment Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 68. Latin America Synovial Sarcoma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Synovial Sarcoma Treatment Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 73. Middle East & Africa Synovial Sarcoma Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. UAE Synovial Sarcoma Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Synovial Sarcoma Treatment Value Chain
Figure 78. Synovial Sarcoma Treatment Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed